Stefanie Reisch
Urology · Fort Worth, TXNPI 1740750397
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by Johnson & Johnson at 24.1% of the total. Reporting peaked in 2023 at $1,772 and has fallen 57.8% since, to $747 in 2025.
Across 263 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Endo Pharmaceuticals Inc.$650
- Astellas Pharma US Inc$475
- Sumitomo Pharma America, Inc.$441
- Pfizer$354
- Myovant Sciences Inc.$284
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,18399%
- Education$891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 47 | $1,513 |
| Endo Pharmaceuticals Inc. | 36 | $650 |
| Astellas Pharma US Inc | 29 | $475 |
| Sumitomo Pharma America, Inc. | 23 | $441 |
| Pfizer | 20 | $354 |
| Myovant Sciences Inc. | 15 | $284 |
| Bayer | 7 | $258 |
| Endo USA, Inc. | 5 | $193 |
| Accord Healthcare, Inc. | 5 | $191 |
| Procept Biorobotics Corporation | 2 | $143 |
| Urovant Sciences Inc | 9 | $139 |
| AbbVie | 8 | $131 |
| AstraZeneca | 1 | $122 |
| Progenics Pharmaceuticals, Inc. | 2 | $122 |
| Telix Pharmaceuticals | 2 | $112 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $105 |
| Medtronic | 4 | $100 |
| Tolmar, Inc. | 5 | $96 |
| Antares Pharma, Inc. | 6 | $94 |
| 180 Medical, Inc. | 4 | $92 |
| Boston Scientific | 5 | $90 |
| Dendreon Pharmaceuticals LLC | 4 | $90 |
| Blue Earth Diagnostics | 4 | $77 |
| Clarus Therapeutics Inc. | 4 | $71 |
| Janssen Scientific Affairs, LLC | 1 | $67 |
| Urogen Pharma, Inc. | 3 | $60 |
| Merck | 3 | $55 |
| Mission Pharmacal Company | 3 | $44 |
| Foundation Medicine, Inc. | 1 | $29 |
| Halozyme Inc | 1 | $22 |
| Olympus America Inc. | 1 | $20 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$774
- AKEEGA$266
- AquaBeam Robotic System$127
- Nubeqa$124
- Xofigo$124
- BREZTRI$122
- CAMCEVI$121
- XIAFLEX$112
- NURTEC ODT$105
- PYLARIFY$103
How this compares
$6,272 in reported general payments places this provider in the 65th percentile of 878 urology providers in Texas.
Other urology in Fort Worth
- Adam HollanderFort Worth$53K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.